A Pricentric Brief by Sean Skulski "In short, parallel imports of medicines into the UK provide both certainty of supply, when there is not enough UK stock (because of a sudden spike in demand), and incentivized purchasing competition which saves the NHS over £100m per annum, on current estimates." - Healthcare Distribution Association UK Council [...]The post Brexit and Parallel Imports-the end of an era? appeared first on Alliance Life Sciences.